Gyroscope Capital Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,700
Closed -$1.27M 235
2023
Q2
$1.27M Buy
2,700
+1,100
+69% +$461K 0.29% 74
2023
Q1
$549K Sell
1,600
-100
-6% -$33.7K 0.14% 110
2022
Q4
$622K Hold
1,700
0.19% 81
2022
Q3
$550K Buy
+1,700
New +$539K 0.21% 75
2020
Q2
Sell
-1,424
Closed -$198K 123
2020
Q1
$198K Sell
1,424
-379
-21% -$52.1K 0.09% 107
2019
Q4
$237K Buy
+1,803
New +$209K 0.09% 111
2019
Q1
Sell
-1,903
Closed -$220K 156
2018
Q4
$220K Sell
1,903
-87,946
-98% -$9.82M 0.08% 133
2018
Q3
$10.3M Buy
89,849
+469
+0.5% +$46.9K 4.24% 1
2018
Q2
$7.63M Buy
89,380
+3,770
+4% +$310K 3.38% 4
2018
Q1
$6.62M Buy
+85,610
New +$6.89M 3.15% 7
2016
Q3
Sell
-3,881
Closed -$306K 99
2016
Q2
$306K Buy
3,881
+479
+14% +$36.1K 0.25% 63
2016
Q1
$245K Buy
+3,402
New +$257K 0.19% 69

Other funds holding LLY

Gyroscope Capital Management Group's LLY Position: Q3 2023 in Review

Gyroscope Capital Management Group sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 2,700 shares — an estimated $1.27M sold.

Gyroscope Capital Management Group first reported a position in LLY in Q1 2016 and held it in 12 quarters. The position peaked at $10.3M in Q3 2018. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Gyroscope Capital Management Group reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • Gyroscope Capital Management Group sold 2,700 Eli Lilly shares in Q3 2023, an estimated $1.27M.
  • Gyroscope Capital Management Group first reported a position in Eli Lilly in Q1 2016 and held it in 12 quarters.
  • Gyroscope Capital Management Group's Eli Lilly position peaked at $10.3M in Q3 2018.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2023, filed 13 Nov 2023.